Particularly, its immunosuppressive capacity is significantly overwhelming compared with the anti-tumor immunity including CD8 T cells, DCs, and NKs, which are impaired in number and function in PDAC TME and therefore drive us to define (III) the Anti-tumor immunity impaired module (15–18). The gene discussed is CD8A; the disease is neoplasm.